Viatris (VTRS) Other financing activities (2020 - 2026)

Viatris' (VTRS) quarterly Other financing activities came in at -$300000.0 in Q1 2026, up 99.73% year-on-year from -$150205.6 in Q1 2025, and up 97.5% quarter-over-quarter from -$12.0 million in Q4 2025.

Viatris (VTRS) Other financing activities (2020 - 2026) Analysis & Trends

Viatris' Other financing activities history runs 7 years deep, the most recent figure standing at -$300000.0 for Q1 2026.

  • On a quarterly basis, Other financing activities rose 99.73% year-over-year to -$300000.0 in Q1 2026; TTM through Mar 2026 was -$80.8 million, a 145.04% decrease from a year earlier, with the FY2025 full-year figure at -$190.1 million, down 164.4% from the prior year.
  • Other financing activities advanced to -$300000.0 in Q1 2026 per VTRS's latest filing, from -$12.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $290.4 million in Q4 2024 and bottomed at -$277.2 million in Q4 2023.
  • The 5-year median for Other financing activities is $3.0 million (2022), against an average of -$3.1 million.
  • Across the five-year window, Other financing activities jumped 17925.0% in 2023 and slumped 1867.74% in 2025, its largest moves.
  • Year by year, Other financing activities stood at $19.2 million in 2022, then slumped by 1543.75% to -$277.2 million in 2023, then jumped by 204.76% to $290.4 million in 2024, then sank by 104.13% to -$12.0 million in 2025, then soared by 97.5% to -$300000.0 in 2026.
  • Per Business Quant, the three latest VTRS Other financing activities figures stand at -$300000.0 (Q1 2026), -$12.0 million (Q4 2025), and -$179.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -300,000.00
Mar 31, 2026 -300,000.00
Dec 31, 2025 -12.00 Mn
Dec 31, 2025 -12.00 Mn
Sep 30, 2025 -179.10 Mn
Sep 30, 2025 -179.10 Mn
Jun 30, 2025 110.60 Mn
Jun 30, 2025 110.60 Mn
Mar 31, 2025 -109.60 Mn
Mar 31, 2025 -109.60 Mn
Dec 31, 2024 290.40 Mn
Dec 31, 2024 290.40 Mn
Sep 30, 2024 -124.00 Mn
Sep 30, 2024 -124.00 Mn
Jun 30, 2024 122.60 Mn
Jun 30, 2024 122.60 Mn
Mar 31, 2024 6.20 Mn
Mar 31, 2024 6.20 Mn
Dec 31, 2023 -277.20 Mn
Dec 31, 2023 -277.20 Mn